Oracle Is Spending Billions on AI. Why It Might Not Pay Off.
Oracle's AI infrastructure spending could reach at least $90 billion in fiscal 2027.
Read more →Trading Venues
Microchip Technology To Acquire Hailo
(RTTNews) - Microchip Technology Inc. (MCHP), a provider of smart, connected, and secure embedded control solutions, announced that it agreed to acquire Hailo, a provider of accelerated edge AI processors, advanced visi…
Read more →NAVER, NVIDIA And Brookfield Plan 200MW Expansion Of Korea's AI Factory Infrastructure
(RTTNews) - NAVER Corp. (NHNCF, 035420.KS), NVIDIA and Brookfield announced plans to expand Korea's sovereign AI factory infrastructure with investments that will grow the initial NVIDIA DSX AI factory deployment from 5…
Read more →SK Group And NVIDIA Expand $500 Bln+ AI Factories And Memory Partnership
(RTTNews) - SK Group and NVIDIA (NVDA) expanded their strategic collaboration with a $500-billion-plus initiative that spans AI factory development and next-generation memory. The two companies signed letters of intent …
Read more →Super Micro Just Delivered Fantastic News to Nvidia Investors
Super Micro expects fourth-quarter revenue to come in at the lower end of its previously issued guidance.
Read more →Zevra To Appeal EMA's Negative Opinion On Arimoclomol For Niemann-Pick Disease Type C
(RTTNews) - Zevra Therapeutics, Inc. (ZVRA) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the company's Marketing Autho…
Read more →FDA Clears Kenvue's TYLENOL With Naproxen, First OTC Fixed-Dose Combination
(RTTNews) - Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) for pain relief.
Read more →Why Apple Stock Is Up Today
The tech leader has found smart ways to benefit from AI without incurring massive costs.
Read more →Outlook Therapeutics Wins FDA Nod For LYTENAVA After Three Setbacks
(RTTNews) - Outlook Therapeutics (OTLK) announced that the FDA has approved LYTENAVA as the first and only FDA-approved ophthalmic formulation of bevacizumab for the treatment of neovascular age-related macular degenera…
Read more →Tech Hits a Wall & Netflix Plunges
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium and Lou Whiteman, along with Motley Fool analyst Emily Flippen, discuss:
Read more →Uber’s New Acquisition and GE Aerospace’s Search for Parts
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
Read more →Bank of America Just Raised Its Dividend 14%. The Buyback Is the Bigger Story.
A typical dividend raise from a blue chip stock usually isn’t very major, with most coming in the low single-digit range. That sure wasn’t the case with Bank of America (NYSE:BAC) on Friday, as the big lender cranked it…
Read more →Does PayPal Have a Buyer?
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
Read more →Verizon Just Signed a More Than $1 Billion Dark Fiber Deal With Google. Here's What It Means for the 6.3% Dividend.
Verizon disclosed a dark fiber agreement with Google worth more than $1 billion, and said more deal announcements are expected by year-end.
Read more →1 Reason Smart Investors Are Loading Up on Coca-Cola Before July 28
Coca-Cola (NYSE: KO), the world's largest beverage company, will post its second-quarter earnings report on July 28. Analysts expect its revenue and adjusted EPS to rise 4% and 7%, respectively, year over year. That gro…
Read more →Corn Finds Buyers to Close Friday Steady
Corn futures were weak early on, but pulled more than 8 cents off the lows in the front months to close fractionally mixed. Some deferreds were down as much as 1 ¼. September was still up 19 ½ cents on the week, with De…
Read more →Why Verizon Stock Climbed Today
Shares of Verizon Communications (NYSE: VZ) rose on Friday after the telecom giant highlighted its new AI-fueled expansion plans.
Read more →10 Years Later: 5 Brexit-Inspired Stocks
In this episode of Motley Fool Rule Breaker Investing, Motley Fool co-founder David Gardner and Motley Fool analyst Karl Thiel revisit the original investment theses for five stocks selected in the anxious days followin…
Read more →Kevin Warsh Just Vowed to Bring a "Regime Change" to the Fed. It Could Rattle Wall Street.
Fed Chair Kevin Warsh has indicated a firm focus on inflation control since taking over for Jerome Powell.
Read more →Big Banks Cash In, IBM Crashes Out
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check out this top 10 list of stocks to buy.
Read more →Chip Stock Sell-off Puts Downward Pressure on Broader Market
The S&P 500 Index ($SPX) (SPY) on Friday fell -0.08%, the Dow Jones Industrial Average ($DOWI) (DIA) rose +0.39%, and the Nasdaq 100 Index ($IUXX) (QQQ) fell -1.27%. September E-mini S&P futures (ESU26) fell -0.08%, and…
Read more →Dollar Little Changed as Oil Prices Fall Back
The dollar index (DXY00) on Friday ended the day little changed. The dollar index was undercut as oil prices fell back by about -3%. Also, the 10-year T-note yield fell -1.8 bp after posting a new 1.5-year high earlier …
Read more →Coffee Prices Rebound Higher After This Week’s Sell-off
September arabica coffee (KCU26) on Friday closed up +4.40 (+1.42%), and September ICE robusta coffee (RMU26) closed up +49 (+1.32%).
Read more →Moderna: A Stock to Watch or a Risky Bet?
Explore the exciting world of Moderna (NASDAQ: MRNA) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential inv…
Read more →